skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: Freely Accessible Journals remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma
Material Type:
Article 		Add to My Research

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

British journal of cancer, 2013-02, Vol.108 (3), p.503-511 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Nature Publishing Group Feb 19, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2012.594 ;PMID: 23361051 ;CODEN: BJCAAI

Full text available

Citations Cited by
2
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV
Material Type:
Article 		Add to My Research

Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV

Journal of acquired immune deficiency syndromes (1999), 2004-08, Vol.36 (5), p.1011-1019 [Peer Reviewed Journal]

2004 Lippincott Williams & Wilkins, Inc. ;2004 INIST-CNRS ;Copyright Lippincott Williams & Wilkins Aug 15, 2004 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/00126334-200408150-00003 ;PMID: 15247553 ;CODEN: JDSRET

Full text available

Citations Cited by
3
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
Material Type:
Article 		Add to My Research

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas

British journal of cancer, 2004-01, Vol.90 (2), p.353-358 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright Nature Publishing Group Jan 26, 2004 ;Copyright © 2003 Cancer Research UK 2003 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/sj.bjc.6601472 ;PMID: 14735176 ;CODEN: BJCAAI

Full text available

Citations Cited by
4
HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia
HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia
Material Type:
Article 		Add to My Research

HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia

Journal of acquired immune deficiency syndromes (1999), 2006-04, Vol.41 (5), p.657-663 [Peer Reviewed Journal]

2006 INIST-CNRS ;Copyright Lippincott Williams & Wilkins Apr 15, 2006 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/01.qai.0000220166.56866.22 ;PMID: 16652041 ;CODEN: JDSRET

Full text available

Citations Cited by
5
Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles : in vivo evaluation of anti-cancer activity
Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles : in vivo evaluation of anti-cancer activity
Material Type:
Article 		Add to My Research

Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles : in vivo evaluation of anti-cancer activity

British journal of cancer, 1996-11, Vol.74 (10), p.1545-1552 [Peer Reviewed Journal]

1997 INIST-CNRS ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.1996.587 ;PMID: 8932333 ;CODEN: BJCAAI

Full text available

Citations Cited by
6
Injecting Equipment Sharing Among Injecting Drug Users in Togliatti City, Russian Federation: Maximizing the Protective Effects of Syringe Distribution
Injecting Equipment Sharing Among Injecting Drug Users in Togliatti City, Russian Federation: Maximizing the Protective Effects of Syringe Distribution
Material Type:
Article 		Add to My Research

Injecting Equipment Sharing Among Injecting Drug Users in Togliatti City, Russian Federation: Maximizing the Protective Effects of Syringe Distribution

Journal of acquired immune deficiency syndromes (1999), 2004-03, Vol.35 (3), p.293-300 [Peer Reviewed Journal]

2004 Lippincott Williams & Wilkins, Inc. ;2004 INIST-CNRS ;Copyright Lippincott Williams & Wilkins Mar 1, 2004 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/00126334-200403010-00011 ;PMID: 15076245 ;CODEN: JDSRET

Full text available

Citations Cited by
7
Intensive induction chemotherapy with C-BOP BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
Intensive induction chemotherapy with C-BOP BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
Material Type:
Article 		Add to My Research

Intensive induction chemotherapy with C-BOP BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)

British journal of cancer, 2005-11, Vol.93 (11), p.1209-1214 [Peer Reviewed Journal]

2006 INIST-CNRS ;Copyright Nature Publishing Group Nov 28, 2005 ;Copyright © 2005 Cancer Research UK 2005 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/sj.bjc.6602830 ;PMID: 16251877 ;CODEN: BJCAAI

Full text available

Citations Cited by
8
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
Material Type:
Article 		Add to My Research

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer

British journal of cancer, 2004-10, Vol.91 (8), p.1434-1441 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright Nature Publishing Group Oct 18, 2004 ;Copyright © 2004 Cancer Research UK 2004 Cancer Research UK ;ISSN: 0007-0920 ;ISSN: 1532-1827 ;EISSN: 1532-1827 ;DOI: 10.1038/sj.bjc.6602172 ;PMID: 15381932 ;CODEN: BJCAAI

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait